Depletion of reactive advanced glycation endproducts from diabetic uremic sera using a lysozyme-linked matrix.
about
Advanced glycation: an important pathological event in diabetic and age related ocular diseaseReceptors for advanced glycosylation endproducts in human brain: role in brain homeostasisA receptor-based bioadsorbent to target advanced glycation end products in chronic kidney disease.Controlling the receptor for advanced glycation end-products to conquer diabetic vascular complicationsQuantitative analysis of glycation patterns in human serum albumin using 16O/18O-labeling and MALDI-TOF MS.Covalent binding antibodies suppress advanced glycation: on the innate tier of adaptive immunity.Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathyThe AGE-receptor in the pathogenesis of diabetic complications.Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation.Reduced acute vascular injury and atherosclerosis in hyperlipidemic mice transgenic for lysozyme.Regulation of RAGE for attenuating progression of diabetic vascular complications.Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney diseaseGlycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesisAGE restriction in diabetes mellitus: a paradigm shift.A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic diseaseReactive immunization suppresses advanced glycation and mitigates diabetic nephropathyRole of advanced glycation endproducts and potential therapeutic interventions in dialysis patients.Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products.Non-enzymatic glycation and glycoxidation protein products in foods and diseases: an interconnected, complex scenario fully open to innovative proteomic studies.Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor.Human recombinant lysozyme downregulates advanced glycation endproduct-induced interleukin-6 production and release in an in-vitro model of human proximal tubular epithelial cells.Amelioration of oxidant stress by the defensin lysozyme.Neurodegenerative diseases of the retina and potential for protection and recoveryMaillard Proteomics: Opening New Pages.
P2860
Q28365776-C30A4F47-AF3E-4314-A231-3090FA481B37Q32085442-D8EF3AF3-7D6C-436B-856C-8A57A7FED37FQ33594667-1CD8EB9B-B977-4C51-87F9-A18B787F327AQ33609776-5F9D5F31-0A63-4B64-A3DC-20F98D3B2E9FQ33907748-1D5CCE74-B3C5-4495-9873-ECE2ED1BC58AQ34287672-B2C0FD40-9A1E-46B0-99BF-E83E8AE375DAQ34388076-66A13459-10AE-44F4-932A-AC0745F39562Q34470639-630A7C2B-3852-44E1-A729-309DFCF07688Q34747124-2FA8EB72-99FF-4F8F-9F40-0D3D5C3441F8Q35221896-9C04DE06-AE44-4DFF-85EB-0994C439C924Q35494903-4A087639-E2B6-4213-8244-12ACBFFE0ED1Q35995060-715CAF73-5DCC-4E1C-837E-8A63FF189E9CQ36052417-44318919-BF53-4CCA-92B0-A6C49617A233Q37003623-92EA933B-3A2F-4D12-B416-EC5A34656FF8Q37097143-111A410B-608D-4E6D-AC4D-41DD26D5208CQ37181988-E4DDBCAA-0D7B-4E48-A0BE-E4428591AC7BQ38006722-96DE8C11-D70F-4FB4-B67A-0600F025A0C3Q38096444-8BED4969-67BE-44FA-97D7-569915771C0FQ38151611-4CEF72E9-93F3-40F0-98AD-E718D1790AD3Q38685706-C7D12C49-C64E-4C0B-B870-60B78749BF84Q39027326-B7BA64F6-EE6B-4DDC-9C73-BF28981627ADQ40346041-80BDE30F-796E-4995-B391-A868A1803892Q41997847-0DA4146C-D26C-4D7B-863D-37E338345786Q47303198-E0E0E464-1A65-4E2A-A27E-14F077BF7F9A
P2860
Depletion of reactive advanced glycation endproducts from diabetic uremic sera using a lysozyme-linked matrix.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Depletion of reactive advanced ...... sing a lysozyme-linked matrix.
@en
Depletion of reactive advanced ...... sing a lysozyme-linked matrix.
@nl
type
label
Depletion of reactive advanced ...... sing a lysozyme-linked matrix.
@en
Depletion of reactive advanced ...... sing a lysozyme-linked matrix.
@nl
prefLabel
Depletion of reactive advanced ...... sing a lysozyme-linked matrix.
@en
Depletion of reactive advanced ...... sing a lysozyme-linked matrix.
@nl
P2093
P2860
P356
P1476
Depletion of reactive advanced ...... sing a lysozyme-linked matrix.
@en
P2093
P2860
P304
P356
10.1172/JCI119600
P407
P577
1997-08-01T00:00:00Z